Why the study?
Do antidiabetic agents affect mortality and harm in patients with diabetes and heart failure?
Do antidiabetic agents affect mortality and harm in patients with diabetes and heart failure?
Metformin appears to be the only safe antidiabetic agent in patients with concurrent diabetes and heart failure, potentially reducing all-cause mortality.
Answers are grounded in this paper and cite their sources.
Supports metformin preference in diabetes with heart failure; extends evidence of its unique safety and mortality signal.
Metformin was the only antidiabetic agent not associated with harm in patients with heart failure and diabetes. It was associated with reduced all cause mortality in two of the three studies.
No takes yet. Share an insight, caveat, or question.
Eurich et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: